ID: ALA5281284

Max Phase: Preclinical

Molecular Formula: C15H11NO2S2

Molecular Weight: 301.39

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(-c2ccc(C(=O)Sc3nccs3)o2)cc1

Standard InChI:  InChI=1S/C15H11NO2S2/c1-10-2-4-11(5-3-10)12-6-7-13(18-12)14(17)20-15-16-8-9-19-15/h2-9H,1H3

Standard InChI Key:  SDKKLEPYYSMVMS-UHFFFAOYSA-N

Associated Targets(Human)

Alpha glucosidase 860 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 301.39Molecular Weight (Monoisotopic): 301.0231AlogP: 4.64#Rotatable Bonds: 3
Polar Surface Area: 43.10Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.90CX LogP: 4.59CX LogD: 4.59
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.66Np Likeness Score: -1.43

References

1. He M, Li YJ, Shao J, Li YS, Cui ZN..  (2023)  Synthesis and biological evaluation of 2,5-disubstituted furan derivatives containing 1,3-thiazole moiety as potential α-glucosidase inhibitors.,  83  [PMID:36764471] [10.1016/j.bmcl.2023.129173]

Source